The utility of dried blood spot measurement of bone turnover markers in biological anthropology

被引:4
|
作者
Devlin, Maureen J. [1 ]
Eick, Geeta N. [2 ]
Snodgrass, J. Josh [2 ,3 ,4 ]
机构
[1] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA
[2] Univ Oregon, Global Hlth Biomarker Lab, Dept Anthropol, Eugene, OR 97403 USA
[3] Univ Oregon, Ctr Global Hlth, Eugene, OR 97403 USA
[4] Hokkaido Univ, Invited Fac, Global Stn Indigenous Studies & Cultural Divers, Sapporo, Hokkaido, Japan
基金
美国国家科学基金会;
关键词
TOTAL-ENERGY EXPENDITURE; ACID-PHOSPHATASE; 5B; PHYSICAL-ACTIVITY; MINERAL CONTENT; POSTCRANIAL ROBUSTICITY; POSTMENOPAUSAL WOMEN; BIOCHEMICAL MARKERS; AMAZONIAN ECUADOR; SERUM OSTEOCALCIN; YAKUT SAKHA;
D O I
10.1002/ajhb.23816
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
Objectives Bone is a dynamic organ under continual turnover influenced by life history stage, energy dynamics, diet, climate, and disease. Bone turnover data have enormous potential in biological anthropology for testing evolutionary and biocultural hypotheses, yet few studies have integrated these biomarkers. In the present article we systematically review the current availability, future viability, and applicability of measuring bone turnover markers (BTMs) in dried blood spot (DBS) samples obtained from finger prick whole blood. Methods Our review considers clinical and public health relevance, biomarker stability in DBS, assay availability, and cost. We consider biomarkers of bone formation such as osteocalcin (bone matrix protein), PINP (N-terminal propeptide of type I collagen), and alkaline phosphatase (osteoblast enzyme), as well as biomarkers of bone resorption such as CTX (marker of collagen breakdown) and TRACP5b (tartrate-resistant acid phosphatase 5b; osteoclast enzyme). Results Two BTMs have been validated for DBS: osteocalcin (formation) and TRACP5b (resorption). Prime candidates for future development are CTX and PINP, the formation and resorption markers used for clinical monitoring of response to osteoporosis treatment. Conclusion BTMs are a field-friendly technique for longitudinal monitoring of skeletal biology during growth, reproduction and aging, combining minimized risk to study participants with maximized ease of sample storage and transport. This combination allows new insights into the effects of energy availability, disease, and physical activity level on bone, and questions about bone gain and loss across life history and in response to environmental factors; these issues are important in human biology, paleoanthropology, bioarchaeology, and forensic anthropology.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] A comparison of the impact of feeding on the biological variability of bone turnover markers
    Clowes, JA
    Hannon, RA
    Yap, TS
    Hoyle, N
    Blumsohn, A
    Eastell, R
    BONE, 2001, 28 (05) : S180 - S181
  • [22] Molecular basis and clinical application of biological markers of bone turnover
    Calvo, MS
    Eyre, DR
    Gundberg, CM
    ENDOCRINE REVIEWS, 1996, 17 (04) : 333 - 368
  • [23] Osteoporosis nurse monitoring clinic: Utility of bone turnover markers.
    Bainbridge, PR
    Hart, S
    Hannon, RA
    Price, A
    Catch, I
    Gray, TA
    Peel, NF
    Eastell, R
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S388 - S388
  • [24] Clinical utility of biochemical bone turnover markers in children and adolescents with osteosarcoma
    Ambroszkiewicz, J.
    Gajewska, J.
    Klepacka, T.
    Chelchowska, M.
    Laskowska-Klita, T.
    Wozniak, W.
    ADVANCES IN MEDICAL SCIENCES, 2010, 55 (02): : 266 - 272
  • [25] Clinical utility of bone turnover markers in patients with chronic kidney disease
    Smout, Dieter
    Jorgensen, Hanne S.
    Cavalier, Etienne
    Evenepoel, Pieter
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2022, 31 (04): : 332 - 338
  • [26] Clinical utility of urinary markers of bone turnover in response to antiresorptive therapies
    Dulipsingh, L
    De Souza, MJ
    Ikram, Z
    Fall, P
    Willard, A
    Fang, ZX
    Prestwood, K
    Raisz, L
    ENDOCRINOLOGIST, 2003, 13 (03): : 293 - 299
  • [27] Utility of bone turnover markers in predicting patient response to ibandronate therapy
    Hochberg, Marc C.
    Silverman, Stuart L.
    Barr, Charles E.
    Miller, Paul D.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S217 - S217
  • [28] The Clinical Utility Of Bone Turnover Markers In The Evaluation Of Bone Disease In Patients With Haemophilia A and B
    Anagnostis, Panagiotis
    Vakalopoulou, Sofia
    Timoleon-Achilleas, Vyzantiadis
    Charizopoulou, Maria
    Mandala, Eudokia M.
    Agapidou, Alexandra
    Vassiliki, Violaki
    Vasilia, Garipidou
    BLOOD, 2013, 122 (21)
  • [29] Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adults
    Glendenning, Paul
    Chubb, S. A. Paul
    Vasikaran, Samuel
    CLINICA CHIMICA ACTA, 2018, 481 : 161 - 170
  • [30] The clinical utility of bone turnover markers in the evaluation of bone disease in patients with haemophilia A and B
    Anagnostis, P.
    Vakalopoulou, S.
    Vyzantiadis, T. -A.
    Charizopoulou, M.
    Karras, S.
    Goulis, D. G.
    Karagiannis, A.
    Gerou, S.
    Garipidou, V.
    HAEMOPHILIA, 2014, 20 (02) : 268 - 275